About Color
Color is a Healthcare company based in Burlingame (United States) founded in 2013 by Elad Gil and Othman Laraki. Cancer care is delivered through a virtual clinic by Color. It operates on a HealthTech and Managed Services model in Healthcare and Technology sectors. Color has raised $491.44 million across 8 funding rounds from investors including NIH, Khosla Ventures and T. Rowe Price. The company has 234 employees. Color has completed 1 acquisition, including Mood Lifters. Color was last valued at $4.6 billion in November 2021. Its chief executive, as recorded, is Othman Laraki. Its website color.com draws about 105 thousand monthly visits. Color offers products and services including Virtual Cancer Clinic and Genetic Testing. Its focus areas include Cancer Care and Virtual Clinics. Its legal entity is Color Health, Inc. Its competitors include 23andMe, Hinge Health and GRAIL; 3 of its 3 listed competitors have raised funding.
Company details
Cancer care is provided by Color through a virtual clinic model, focusing on early detection, treatment, and ongoing support. Services are extended to employers, health plans, unions, and public sector entities. Risk assessment, screening adherence, and direct care are facilitated by an in-house medical team licensed across all 50 states. Solutions are designed to improve outcomes and reduce costs by addressing care gaps and accelerating diagnosis. Support is offered across physical, mental, and financial needs, ensuring accessibility regardless of geography or insurance coverage.
- Annual Revenue$241.3 K (USD)20as on Dec 31, 2023
- Net Profit$18.81 K (USD)23as on Dec 31, 2023
- Total Equity Funding$491.44M (USD)
in 8 rounds
- Latest Funding Round$100M (USD), Series E
Oct 2021
- InvestorsNIH
& 44 more
- Employee Count234
- Investments & Acquisitions
Products & Services of Color
Color offers a comprehensive portfolio of products and services, including Virtual Cancer Clinic and Genetic Testing.
Cancer care is provided through virtual clinic services.
Genetic testing is offered for cancer risk assessment.
Funding Insights of Color
Color has successfully raised a total of $491.44M across 8 strategic funding rounds. The most recent funding activity was a Series E round of $100 million completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $491.44M
- Total Rounds 8
- Last Round Series E — $100M
- First Round $15M
(Apr 2015)
- Investors Count 45
All 8 funding rounds of Color with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2021 | $100M | Series E | $4.6B | Kindred Ventures, T. Rowe Price | |
| Dec 2020 | $167M | Series D | $1.5B | General Catalyst | |
| Jan 2020 | $75M | Series D | – | Viking Global Investors, T. Rowe Price | – |
| Aug 2019 | $4.6M | Grant | – | – | |
| Aug 2017 | $89.44M | Series C | – | General Catalyst | |
| Aug 2016 | $45M | Series B | – | General Catalyst | |
| Apr 2015 | $15M | Series A | – | Khosla Ventures, Formation 8 | |
| Apr 2015 | $15M | Series A | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Oct 2021 | $4.6B | •••••••• |
| Dec 2020 | $1.5B | •••••••• |
Full valuation and stage history of Color
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $4.6B (Nov 2021). 45 investors in total: 33 institutional and 12 angel.
Investors in Color
Color has secured backing from 45 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include NIH, Khosla Ventures and T. Rowe Price.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed-stage investments in multiple sectors are made by Kindred Ventures. | kindredventures.com | San Francisco, United States | ||
Investment and transformation services for entrepreneurs in technology and finance sectors. | generalcatalyst.com | Cambridge, United States | ||
Private investment firm focused on multiple sectors | vikingglobal.com | Greenwich, United States | ||
CRV is recognized as a venture capital firm investing in technology startups. | crv.com | Palo Alto, United States | ||
Venture capital firm investing in technology, life sciences, and related sectors. | 8vc.com | |||
Early-stage startups are funded by this venture capital firm. | 2004 | khoslaventures.com | Menlo Park, United States | |
AME Cloud Ventures is focused on investing in data-driven technology companies. | amecloudventures.com | Palo Alto, United States | ||
VC Firm investing in the US | formation8.com | San Francisco, United States | ||
Early-stage technology investments are targeted by this venture capital firm. | innovationendeavors.com | Palo Alto, United States | ||
Early-stage investments are provided to transformative technology companies. | svangel.com | San Francisco, United States |
Investor details for Color
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Color
98 people are tracked at Color (37 in leadership, 61 in team); the tracked headcount is 234.
| Name | Role | Group |
|---|---|---|
Elad Gil | Co-Founder | Leadership |
Othman Laraki | Co-Founder & CEO | Leadership |
Nicole Elovitz | Vice President Marketing | Leadership |
Paul Wang | Vp, Creative Director | Leadership |
Joshua Sturm | Chief Revenue Officer (cro) | Leadership |
Mark Becerra | Senior Director Of Engineering | Leadership |
Stephan Meyer-Ewald | Chief People Officer | Leadership |
Rebecca Miksad | Chief Medical Officer | Leadership |
Priscila de Alcântara Loghry | Head of Facilities & Workplace | Leadership |
Kate Botler Kodesh | Chief People Officer | Leadership |
Mike Quigg | Vp, National Leader, Strategic Partnerships & Business Development | Leadership |
Stephanie Lewis | Senior Director, Product Design | Leadership |
Alicia Zhou | Chief Science Officer | Leadership |
Scott Topper | Chief Clinical Operations Officer | Leadership |
Serra Kim | Head of Variant Science | Leadership |
Tyler Lefeber | Director, Business Development, Labor & Trust | Leadership |
John O'Reilly | Director | Leadership |
Keegan Duchicela | Director Of Medical Affairs | Leadership |
Lee Mallabone | VP Of Engineering | Leadership |
Sarah Turrin | Chief Product Officer | Leadership |
78 more people are available in the full profile.
Complete people profiles for Color
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Color
Color has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Mood Lifters.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Mental wellness programs are provided for emotional support. | moodlifters.com | Ann Arbor, United States | 2006 | Oct 2022 | •••• |
Complete acquisition details for Color
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Color
5 dated milestones of Color across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Color is founded.
- Funding First funding round of $15.0M.
- Milestone Reaches Unicorn status.
- Funding Latest funding round, Series E, of $100.0M.
- Acquisition Acquires Mood Lifters.
Competitors of Color
Color has 3 listed competitors in our database, 3 of them funded. They include 23andMe, Hinge Health and GRAIL.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 23andme.com | 2006 | Sunnyvale, United States | $943.53M | 755 | Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | |
| hingehealth.com | 2015 | San Francisco, United States | $854.44M | 1,442 | Virtual physical therapy and digital pain care solutions are provided. | |
| grail.com | 2016 | Menlo Park, United States | $2B | 491 | Circulating tumor DNA is screened for early cancer detection. |
Detailed competitors of Color
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Color
The website of Color (color.com) receives about 105.4K visits a month.
- Monthly visits105.4K
▲ 21.6% vs previous month
Websites whose visitors overlap most with Color. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
densebreast-info.org | densebreast-info.org | 100% | #1,126,274 | – | |
joinallofus.org | joinallofus.org | 65% | #136,958 | – | |
| mobihealthnews.com | 50% | 133.6K | #351,855 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Color (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Color
Complete news archive for Color
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Color
Color was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Color is headquartered in Burlingame, United States. It is registered at Burlingame, California, United States.
Othman Laraki is the CEO of Color, as recorded in our data. They have also founded this company.
Color is a funded company, having raised a total of $491.44M across 8 funding rounds to date. The company's 1st funding round was a Series A of $15M, raised on Apr 2015.
Color has 234 employees.
Annual revenue of Color is $241.3K as on Dec 31, 2023.
Cancer care is provided by Color through a virtual clinic model, focusing on early detection, treatment, and ongoing support. Services are extended to employers, health plans, unions, and public sector entities. Risk assessment, screening adherence, and direct care are facilitated by an in-house medical team licensed across all 50 states. Solutions are designed to improve outcomes and reduce costs by addressing care gaps and accelerating diagnosis. Support is offered across physical, mental, and financial needs, ensuring accessibility regardless of geography or insurance coverage.
Color's top competitors include Hinge Health, GRAIL and 23andMe.
Color offers Virtual Cancer Clinic and Genetic Testing.
Color has made 1 acquisition, including Mood Lifters.
Color has 45 investors. Key investors include NIH, Khosla Ventures, T. Rowe Price, Kindred Ventures, and General Catalyst.
The valuation of Color is $4.6B as of Nov 2021.